These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 30176671)
21. Comparing intravitreal triamcinolone acetonide and bevacizumab injections for the treatment of diabetic macular oedema: a randomized double-blind study. Isaac DL; Abud MB; Frantz KA; Rassi AR; Avila M Acta Ophthalmol; 2012 Feb; 90(1):56-60. PubMed ID: 20015098 [TBL] [Abstract][Full Text] [Related]
22. Injection of triamcinolone acetonide into the posterior sub-tenon capsule for treatment of diabetic macular edema. Toda J; Fukushima H; Kato S Retina; 2007; 27(6):764-9. PubMed ID: 17621188 [TBL] [Abstract][Full Text] [Related]
26. Early change of central macular thickness after intravitreous triamcinolone or bevacizumab in diabetic macular edema or retinal vein occlusion. Sonoda Y; Arimura N; Shimura M; Sakamoto T Retina; 2011 Feb; 31(2):290-7. PubMed ID: 21102366 [TBL] [Abstract][Full Text] [Related]
33. Posterior Subtenon's Capsule Triamcinolone Acetonide Injection for the Treatment of Diabetic Macular Edema. Ozkurt YB; Akkaya S; Aksoy S; Evciman T; Haboğlu M J Ocul Pharmacol Ther; 2015 Oct; 31(8):455-60. PubMed ID: 26154736 [TBL] [Abstract][Full Text] [Related]
34. Repeated intravitreal high-dosage injections of triamcinolone acetonide for diffuse diabetic macular edema. Jonas JB; Spandau UH; Kamppeter BA; Vossmerbaeumer U; Harder B; Sauder G Ophthalmology; 2006 May; 113(5):800-4. PubMed ID: 16530840 [TBL] [Abstract][Full Text] [Related]
35. A randomized, placebo-controlled clinical trial of intravitreal triamcinolone for refractory diabetic macular edema. Dehghan MH; Ahmadieh H; Ramezani A; Entezari M; Anisian A Int Ophthalmol; 2008 Feb; 28(1):7-17. PubMed ID: 17589809 [TBL] [Abstract][Full Text] [Related]
36. Duration of the effect of intravitreal triamcinolone acetonide as treatment for diffuse diabetic macular edema. Jonas JB; Degenring RF; Kamppeter BA; Kreissig I; Akkoyun I Am J Ophthalmol; 2004 Jul; 138(1):158-60. PubMed ID: 15234306 [TBL] [Abstract][Full Text] [Related]
37. Resolution of Pseudophakic Cystoid Macular Edema: 2 mg Intravitreal Triamcinolone Acetonide versus 40 mg Posterior Sub-Tenon Triamcinolone Acetonide. Kuley B; Storey PP; Wibbelsman TD; Pancholy M; Zhang QE; Sharpe J; Bello N; Obeid A; Regillo C; Kaiser RS; Chiang A; Fineman MS; Vander JF; Gupta OP; Spirn MJ; Dunn JP; Mehta S; Park CH; Maguire JI; Garg S Curr Eye Res; 2021 Jun; 46(6):824-830. PubMed ID: 33522311 [TBL] [Abstract][Full Text] [Related]
39. Long-term results of a single injection of intravitreal dexamethasone as initial therapy in diabetic macular edema. Mahapatra SK; Kumari S Indian J Ophthalmol; 2020 Mar; 68(3):490-493. PubMed ID: 32057010 [TBL] [Abstract][Full Text] [Related]
40. Intravitreal triamcinolone acetonide versus combined intravitreal bevacizumab and dexamethasone in diffuse diabetic macular oedema. Sheth S; Rush R; Natarajan S; Gillies M Clin Exp Ophthalmol; 2011; 39(7):673-81. PubMed ID: 22452685 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]